Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion
article
OA: gold
CC0
⤵ 1 in-corpus citation
Abstract
Matrix metalloproteinases (MMPs) cleave proteins of extracellular matrix thus facilitating cellular invasion and cancer progression. High MMP-2 activity is frequently reported in several diseases including endometriosis and cancer. Endometriosis, though benign causing pain and infertility, rarely culminate into ovarian cancer. New diagnostic markers are needed for early diagnosis and proper therapeutic avenues since the only diagnostic method is laparoscopy to date. Emerging evidence shows the importance of MMP activity and involvement of noncoding RNA, e.g. miRNA thereon. We investigated the role of miRNA-34a in MMP-2-mediated regulation of invasion and tumorigenesis in endometriosis. Database analysis showed a decreased miRNA-34a in different gynecological malignancies. qRT-PCR with human endometriotic and control tissues revealed a significant elevation in MMP-2 activity with downregulated miR-34a in diseased individuals proving an inverse correlation between miRNA-34a and MMP-2. Luciferase assay in SK-OV-3 cells demonstrated that miRNA-34a-5p directly binds the 3′UTR of the MMP-2 promoter to reduce its transcription followed by suppression of invasion. The zymographic assay also showed a reduced MMP-2 activity upon miR-34a treatment in End1/E6E7 and SK-OV-3 cells. We also found that miRNA-34a-5p inhibits invasion, migration, colony/spheroid formation, and stemness of the cells thereby reducing in vitro tumorigenesis. Subsequently, the immunoblotting results confirmed that MMP-2, and mesenchymal markers like n-cadherin, vimentin, and slug expression were downregulated, whereas the e-cadherin was upregulated in the cells treated with miRNA-34a mimic. Our study demonstrates the direct binding of miR-34a-5p with the MMP-2 gene's 3′UTR and thus repressed its transcription as well as suppressing endometriosis progression. • miRNA-34a-5p downregulation in endometriosis causes EMT and tumorigenesis. • miRNA-34a directly binds to the 3′UTR of MMP-2 gene to inhibit its transcription. • miRNA-34a regulates EMT and tumorigenesis by directly targeting the MMP-2 promoter. • miRNA-34a-5p also regulates colony/spheroid formation, and stemness of the cells. • miRNA-34a loss aggravates endometriosis proving its pathophysiological significance.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (46)
- Curcumin as anti-endometriotic agent: Implication of MMP-3 and intrinsic apoptotic pathway via openalex
- Down-Regulation of Endometrial Matrix Metalloproteinase-3 and -7 Expression<i>in Vitro</i>and Therapeutic Regression of Experimental Endometriosis<i>in Vivo</i>by a Novel Nonsteroidal Progesterone Receptor Agonist, Tanaproget via openalex
- EGFR‐mediated matrix metalloproteinase‐7 up‐regulation promotes epithelial‐mesenchymal transition <i>via</i> ERK1‐AP1 axis during ovarian endometriosis progression via openalex
- Endometriosis and risk of ovarian cancer: what do we know? via openalex
- Informing women with endometriosis about ovarian cancer risk via openalex
- Interleukin‐1β activated c‐FOS transcription factor binds preferentially to a specific allele of the matrix metalloproteinase‐13 promoter and increases susceptibility to endometriosis via openalex
- Peritoneal Modulators of Endometriosis-Associated Ovarian Cancer via openalex
- Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis Promotes Angiogenesis in Endometriosis via openalex
- Role of melatonin in regulating matrix metalloproteinase‐9 via tissue inhibitors of metalloproteinase‐1 during protection against endometriosis via openalex
- Role of repressed microRNAs in endometriosis via openalex
- The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target via openalex
- W2305644015 via openalex
- W2594205397 via openalex
- W2616122337 via openalex
- W2619809886 via openalex
- W2667536409 via openalex
- W2742790202 via openalex
- W2792995236 via openalex
- W2793102726 via openalex
- W2794087648 via openalex
- W2884088390 via openalex
- W2884113901 via openalex
- W2914640215 via openalex
- W2921638830 via openalex
- W2944094525 via openalex
- W3021503750 via openalex
- W3112403429 via openalex
- W3127581156 via openalex
- W3132843131 via openalex
- W3135601979 via openalex
- W3157744878 via openalex
- W3198113004 via openalex
- W4372342208 via openalex
- W6762550190 via openalex
- W1970431885 via openalex
- W6791780785 via openalex
- W1976875491 via openalex
- W2004112393 via openalex
- W2008893427 via openalex
- W2022322735 via openalex
- W2042762614 via openalex
- W2061090407 via openalex
- W2090464574 via openalex
- W2104268053 via openalex
- W2142501544 via openalex
- W2171875732 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pmc
- last seen: 2026-05-13T20:22:03.195721+00:00
- pubmed
- last seen: 2026-05-25T00:31:40.731709+00:00
License: CC0
· commercial use OK